When you think of GLP-1s and investing, the two large pharmaceutical companies benefiting most from this trend may first come to mind. First, there's Novo Nordisk, the first to bring GLP-1 weight loss ...

Viking Therepeutics' VK2735 candidate is a dark horse contender among GLP-1 weight loss drugs. If upcoming late-stage clinical trial results prove positive, Viking's value as a takeover target could ...

ORANGEBURG, S.C. — Construction is now underway on a new biotechnology and innovation center at Claflin University, a project leaders say will transform how students learn and prepare for future ...

Altman talked to Laurie Segall, CEO of Mostly Human, about his takeaways from the Pentagon deal. Altman said he had "miscalibrated" the mood of distrust toward AI and the government. Altman said that ...

A consortium of JGC, Technip Energies and Samsung Heavy Industries has launched bidding for the module work on a second floating liquefied natural gas (FLNG) unit set for deployment offshore ...

Sam Altman, OpenAI’s CEO and the public face of ChatGPT, has carved out an image for himself as one of the preeminent AI whisperers of our age, whose influence supposedly extends to the White House on ...

Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of ...

US dollar-denominated funds could face more hurdles when investing in Chinese tech and biotech companies as Beijing adopts a stricter approach to companies seeking listings via offshore incorporated ...

Iowa Hawkeyes tight end Sam LaPorta runs an official 4.59-second 40-yard dash at the 2023 NFL Scouting Combine. NFL Analyst Marc Ross talks about which prospects draft stock rose from their ...

In the fall of 2023, Ilya Sutskever, OpenAI’s chief scientist, sent secret memos to three fellow-members of the organization’s board of directors. For weeks, they’d been having furtive discussions ...